Plan to Install New Pharmaceutical Manufacturing Equipment at the Yamaguchi Plant
First written in FY2017-Q3. 3 of 8 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2020.
0 other companies' latest entry also says "Achieved".
- FY2020AchievedAnnual report
「The Yamaguchi Plant was completed on 12 July 2019.」
The pharmaceutical manufacturing facilities at the Yamaguchi Plant, planned in 2017, reached the completion milestone marking the end of the plan. - FY2019AdvancedAnnual report
「The Company; Yamaguchi Plant (Yamaguchi City, Yamaguchi Prefecture); Pharmaceutical business; Pharmaceutical manufacturing facilities; ¥21,000 million; ¥16,895 million; Internal funds; August 2017; August 2019」
For the pharmaceutical manufacturing facilities at the Yamaguchi Plant, the amount already paid increased to ¥16.895 billion out of the total investment of ¥21.0 billion, and the construction plan, scheduled for completion in August 2019, remains ongoing. - FY2019-Q3Construction ongoing, commitment reducedAnnual report
「At the end of the 3rd quarter consolidated accounting period, commitments for expenditures on property, plant and equipment primarily related to factory facilities under construction in Yamaguchi Prefecture.」
The factory facilities in Yamaguchi Prefecture remain under construction, and expenditure commitments for property, plant and equipment are ¥3,191 million. No new capital investment plans or completion are reported. - FY2019-Q1RestatedAnnual report
「At the end of the 1st quarter consolidated accounting period, commitments for expenditures on property, plant and equipment primarily related to factory facilities under construction in Yamaguchi Prefecture.」
The factory facilities in Yamaguchi Prefecture remain under construction, and expenditure commitments for property, plant and equipment are stated at ¥9,262 million. No new completion or plan changes are reported. - FY2018AdvancedAnnual report
「The Company, Yamaguchi Plant (Yamaguchi City, Yamaguchi Prefecture), Pharmaceutical manufacturing facilities, 21,000, 6,269, Internal funds, August 2017, August 2019」
For the pharmaceutical manufacturing facilities at the Yamaguchi Plant, ¥6.269 billion of the total investment of ¥21 billion had been spent, and the construction plan remained scheduled for completion in August 2019. - FY2018-Q3RestatedAnnual report
「At the end of the 3rd quarter consolidated accounting period, commitments for expenditures on property, plant and equipment primarily related to factory facilities under construction in Yamaguchi Prefecture.」
Factory facilities in Yamaguchi Prefecture remained under construction, and commitments for expenditures on property, plant and equipment at the end of the 3rd quarter were stated at ¥16,040 million. - FY2018-Q2AdvancedAnnual report
「At the end of the second quarter accounting period, commitments for expenditures on property, plant and equipment primarily related to factory facilities under construction in Yamaguchi Prefecture.」
The pharmaceutical manufacturing facilities at the Yamaguchi Plant planned in the previous fiscal year were under construction at the end of the quarter, with commitments for capital expenditures stated at ¥17,794 million. - FY2017-Q3First statedAnnual report
「The following newly finalized major capital expenditure project was identified during the 3rd quarter consolidated cumulative period. / The Company, Yamaguchi Plant (Yamaguchi City, Yamaguchi Prefecture), Pharmaceutical business, Pharmaceutical manufacturing facilities, 21,000, 471, Internal funds, August 2017, August 2019」
A specific capital expenditure plan was disclosed for the first time to establish pharmaceutical manufacturing facilities at the Yamaguchi Plant at a total cost of ¥21 billion, with construction scheduled to start in August 2017 and be completed in August 2019.